Kiromic Biopharma, Inc. (KRBPQ) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: August 08, 2025
Kiromic Biopharma, Inc. (KRBPQ) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Kiromic Biopharma, Inc. (Stock Symbol: KRBPQ)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Market Capitalization: $0 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Kiromic Biopharma, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Kiromic Biopharma, Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Kiromic Biopharma, Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Kiromic Biopharma, Inc. interactive price chart and technical analysis...
Deep dive into Kiromic Biopharma, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Kiromic Biopharma, Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Kiromic Biopharma, Inc.:
Market Cap$0M
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Kiromic Biopharma, Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Kiromic Biopharma, Inc.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Kiromic Biopharma, Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Kiromic Biopharma, Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Kiromic Biopharma, Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Kiromic Biopharma, Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Kiromic Biopharma, Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Kiromic Biopharma, Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Kiromic Biopharma, Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Kiromic Biopharma, Inc.:
Income Statement ($ Millions)
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding2M
Kiromic Biopharma, Inc. (KRBPQ) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Kiromic Biopharma, Inc. stock analysis.
Loading fundamental data...
Loading Kiromic Biopharma, Inc. comprehensive fundamental analysis and insider trading data...
Latest Kiromic Biopharma, Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting Kiromic Biopharma, Inc. (KRBPQ) stock price and investment outlook.
Kiromic BioPharma Reports Favorable Ongoing Clinical Results From Fourth and Sixth Patients Enrolled in Deltacel-01 HOUSTON, October 08, 2024--Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the ...
HOUSTON, January 21, 2025--Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports favorable efficacy results from the 12-month follow-up visit for the first patient and the two ...
Kiromic BioPharma Inc (NASDAQ: KRBP) shares are gaining Wednesday morning. However, there is no specific news today. During the session, the share price reached $9.22. Monday morning, the FDA ...
Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND ® artificial intelligence (AI ...
Kiromic BioPharma, Inc. reports favorable early efficacy results from the first patient enrolled in the Phase 1 Deltacel-01 clinical trial with Deltacel™ for treating stage 4 metastatic non ...
SAN FRANCISCO, Nov. 8, 2022 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Kiromic Biopharma, Inc. (NASDAQ: KRBP) relating ...
Kiromic BioPharma, Inc. is an immuno-oncology biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology applications through its robust product pipeline.
Kiromic BioPharma, Inc. is a target discovery and gene-editing company utilizing a state-of-the-art artificial intelligence (AI) platform focused on unleashing the power of the patient’s own ...
Kiromic BioPharma, Inc. (Nasdaq: KRBP) (the “Company”), an immuno-oncology target discovery and gene-editing company with a proprietary artificial intelligence neural network ...
Kiromic Biopharma Inc (NASDAQ: KRBP) shares are trading higher by 78.5% at $0.50 after the company entered a Sponsored Research Agreement (SRA) under which in vivo preclinical data will be ...
Kiromic Biopharma, Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of Kiromic Biopharma, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - Kiromic Biopharma, Inc. Stock Forecast
How accurate are Kiromic Biopharma, Inc. stock predictions?
Our AI model demonstrates -7% historical accuracy for KRBPQ predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Kiromic Biopharma, Inc. stock price forecasts?
Is Kiromic Biopharma, Inc. a good investment in 2025?
Based on our AI analysis, Kiromic Biopharma, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Kiromic Biopharma, Inc. forecasts updated?
Kiromic Biopharma, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Kiromic Biopharma, Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Kiromic Biopharma, Inc. stock.
